SEC Filings | PureTech Health

Filing date	Form	Description	Filing Group	View
2021-02-16	SC 13G	A statement of beneficial ownership of common stock by certain persons	Other	0000914208-21-000319.pdf 0000914208-21-000319.rtf 0000914208-21-000319.xls View HTML
2020-11-09	20FR12B/A	Amendment to a previously filed 20FR12B	Registration Statements	0001193125-20-288657.pdf 0001193125-20-288657.rtf 0001193125-20-288657.xls View HTML
2021-02-10	SC 13D/A	An amendment to a SC 13D filing	Other	0001193125-21-035223.pdf 0001193125-21-035223.rtf 0001193125-21-035223.xls View HTML
2020-09-22	DRS	Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy	Registration Statements	0000950123-20-009894.pdf 0000950123-20-009894.rtf 0000950123-20-009894.xls View HTML
2020-11-12	EFFECT	EFFECT	Other	9999999995-20-003161.xls View HTML
2020-11-02	F-6	Registration of depository shares evidenced by American Depository Receipts	Registration Statements	0001193805-20-001366.pdf 0001193805-20-001366.rtf 0001193805-20-001366.xls View HTML
2020-10-27	20FR12B	Registration of securities of foreign private issuers 12 (b) of the Securities Exchange Act	Registration Statements	0001193125-20-278627.pdf 0001193125-20-278627.rtf 0001193125-20-278627.xls View HTML
2021-04-15	20-F	Registration of securities of foreign private issuers pursuant to section 12(b) or (g)	Annual Filings	0001628280-21-006938.pdf 0001628280-21-006938.rtf 0001628280-21-006938.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
2021-01-29	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001193125-21-021507.pdf 0001193125-21-021507.rtf 0001193125-21-021507.xls View HTML
2021-02-05	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001193125-21-029720.pdf 0001193125-21-029720.rtf 0001193125-21-029720.xls View HTML

Data provided by Kaleidoscope.